Benefits
Absorption without stomach acid
In 11 fasting people with no stomach acid (achlorhydria), about 45% of the calcium from citrate was absorbed versus about 4% from carbonate. In 9 people with normal stomach acid the two forms were absorbed equally, and carbonate was absorbed normally by the achlorhydric patients when taken with breakfast. The advantage of citrate is clearest when calcium is taken without food in people with low stomach acid.
Effect on urine stone-risk markers
In a small trial, 18 healthy postmenopausal women took 400 mg of calcium twice daily as citrate for 2 weeks. Urinary calcium and citrate rose and urinary oxalate fell, while calcium oxalate, brushite and uric acid saturation did not change compared with placebo. This was a short check in women without stones, not a test of stone prevention.
Bone density support
In a placebo-controlled trial in women within about 10 years of menopause, 800 mg of calcium a day as citrate (400 mg twice daily) kept spine and forearm bone density stable over 2 years, while spine density fell by 2.4% and forearm density by 3.0% on placebo. Hip (femoral neck) density did not change in either group. Fractures were not measured.
Mechanism of action
Absorption that does not depend on stomach acid
Calcium carbonate needs acid to dissolve, while calcium citrate does not. This is why, in fasting people without stomach acid, calcium from citrate was absorbed far better than from carbonate. With a meal, carbonate was absorbed normally.
Citrate in urine
Citrate in urine binds calcium, which lowers the amount free to form calcium oxalate crystals. In a 2-week trial, calcium citrate raised urinary citrate in healthy postmenopausal women but also raised urinary calcium, so overall calcium oxalate saturation did not change.
Standard Calcium Absorption
Once dissolved, calcium absorbs via vitamin D-dependent active transcellular transport and passive paracellular transport — same as calcium from any source.
Clinical trials
Comparison of fractional calcium absorption from calcium carbonate and a pH-adjusted calcium citrate, 0.25 g calcium, measured by a double-isotope method in fasting subjects (Recker 1985, N Engl J Med)
11 fasting patients with achlorhydria and 9 fasting healthy subjects.
In achlorhydria, absorption was 45% from citrate versus 4% from carbonate (p<0.0001). In healthy subjects, absorption was similar (24% versus 23%). Carbonate taken with breakfast was absorbed normally by the achlorhydric patients.
Randomized, placebo-controlled trial of 800 mg/day calcium as citrate (400 mg twice daily) for 1 to 2 years (Ruml et al. 1999, Am J Ther)
63 women in the early or mid postmenopausal period; bone density data for 25 on calcium citrate and 31 on placebo.
Spine (L2 to L4) bone density did not change on calcium citrate (+1.0% at 2 years) but fell 2.4% on placebo; radial shaft fell 3.0% on placebo and did not change on citrate. Femoral neck did not change in either group. Bone turnover markers fell during some treatment periods.
Randomized 4-phase trial of placebo, calcium citrate (400 mg calcium twice daily), potassium citrate, or both, each for 2 weeks (Sakhaee et al. 2004, J Urol)
18 healthy postmenopausal women without kidney stones.
Compared with placebo, calcium citrate raised urinary calcium and citrate and lowered urinary oxalate and phosphate. Urinary saturation of calcium oxalate, brushite and uric acid did not change. Adding potassium citrate raised urinary citrate further.